EUVIMEDEUVIMED entdecken
VergleichsstudieKohortenstudieOpen Access · CC BY-NC-ND 4.0

Effectiveness and safety of combining thiazides with loop diuretics vs . loop diuretics monotherapy in patients with acute decompensated heart failure: A retrospective cohort study

Chia-Chen Hsu iD, Hsien-Chih Chiu, Ju-Chieh Wung, Yueh-Ching Chou, Yuh-Lih Chang, Chian-Ying Chou, Chin-Chou Huang iD

British Journal of Clinical Pharmacology · 2026

DOI: 10.1002/bcp.70257 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift British Journal of Clinical Pharmacology, 2026. Verfasst von Chia-Chen Hsu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Taipei Veterans General Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Heart Failure, Sodium Potassium Chloride Symporter Inhibitors, Hydrochlorothiazide. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Science and Technology Council, Taipei Veterans General Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

This study investigated factors associated with and outcomes of combined loop diuretics with hydrochlorothiazide (HCTZ) for acute decompensated heart failure (ADHF).

Methods

In this retrospective study, adults hospitalized for ADHF and who received intravenous loop diuretics between January 2016 and March 2023 were enrolled. Patients were categorized into two groups based on HCTZ use. Factors associated with combination therapy and clinical outcomes were examined. Effectiveness outcomes included weight change and percentage weight change, while safety outcomes focused on acute kidney injury (AKI) and worsening renal function at discharge.

Results

Among 3493 enrolled patients, 329 received combination therapy. Factors associated with combination therapy included use of thiazide diuretics pre‐admission (adjusted odds ratio [aOR]: 1.81; 95% confidence interval [CI]: 1.25–2.62), pre‐admission dose of oral loop diuretics (aOR: 1.28 per defined daily dose; 95% CI: 1.05–1.56), lower estimated glomerular filtration rate (aOR: 0.98 per unit; 95% CI: 0.98–0.99), higher N‐terminal pro‐B‐type natriuretic peptide levels (aOR: 1.02 per 1000 unit; 95% CI: 1.01–1.02), and lower serum albumin (aOR: 0.53 per unit; 95% CI: 0.41–0.68). Compared to loop diuretics monotherapy, weight reduction was greater in combination therapy (adjusted difference −1.2 kg; 95% CI: −1.5 to −0.9) and percentage of weight loss (adjusted difference −1.8%; 95% CI: −2.3 to −1.3), but higher risk of AKI (aOR: 2.7; 95% CI: 2.1–3.5) and worsening renal function at discharge (aOR: 2.4; 95% CI: 1.9–3.1).

Conclusions

Combination therapy enhanced weight reduction in ADHF; however, it might increase the risk of renal dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureSodium Potassium Chloride Symporter InhibitorsHydrochlorothiazideHumansRetrospective StudiesMaleFemaleAgedDrug Therapy, CombinationMiddle AgedAcute Kidney InjuryTreatment OutcomeAged, 80 and overAcute DiseaseGlomerular Filtration Rate

Stichwörter der Autor:innen

diureticseffectivenessheart failurehydrochlorothiazidesafetythiazide diuretics

Substanzen

Sodium Potassium Chloride Symporter InhibitorsHydrochlorothiazide

Autor:innen und Institutionen

  • Department of Pharmacy, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Department of Pharmacy, College of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Department of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan.
  • Institute of Pharmacology, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
  • School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.

ORCID-Profile: Chia-Chen Hsu, Chin-Chou Huang

Förderung

  • National Science and Technology Council
  • Taipei Veterans General Hospital

Zitieren

APA

Hsu, C. C., Chiu, H. C., Wung, J. C., Chou, Y. C., Chang, Y. L., Chou, C. Y., & Huang, C. C. (2026). Effectiveness and safety of combining thiazides with loop diuretics vs . loop diuretics monotherapy in patients with acute decompensated heart failure: A retrospective cohort study. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70257

Vancouver

Hsu CC, Chiu HC, Wung JC, Chou YC, Chang YL, Chou CY, et al. Effectiveness and safety of combining thiazides with loop diuretics vs . loop diuretics monotherapy in patients with acute decompensated heart failure: A retrospective cohort study. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70257

BibTeX
@article{Hsu2026,
  author = {Hsu, Chia-Chen and Chiu, Hsien-Chih and Wung, Ju-Chieh and Chou, Yueh-Ching and Chang, Yuh-Lih and Chou, Chian-Ying and Huang, Chin-Chou},
  title = {Effectiveness and safety of combining thiazides with loop diuretics vs . loop diuretics monotherapy in patients with acute decompensated heart failure: A retrospective cohort study},
  journal = {British Journal of Clinical Pharmacology},
  year = {2026},
  doi = {10.1002/bcp.70257}
}
Kostenlos starten →